Primary pulmonary artery sarcoma: Report of three cases and review of the literature

Clinical Lung Cancer

Volumn 8, Issue 4, 2007, Pages 277-281

  Manso, Luis ^a   Alvarez, Elena ^a   Quintela, Miguel ^a   Cortes Funes, Hernan ^a   Hitt, Ricardo ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Anthracyclines; Doxorubicin; Dyspnea; Ifosfamide; Thromboembolism

Indexed keywords

CISPLATIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; GEMCITABINE; HEPARIN; IFOSFAMIDE; NAVELBINE; PACLITAXEL;

ADULT; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG EMBOLISM; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PULMONARY ARTERY DISEASE; SARCOMA; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 33847378990     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2007.n.007     Document Type: Article

References (44)

1. Dail DH, Hammar SP, eds. Pulmonary Pathology. 2nd ed. New York, NY: Springer-Verlag Inc; 1994:1387-1389.
2. Pagni S, Passik CS, Riordan C. Sarcoma of the main pulmonary artery: an unusual etiology of recurrent pulmonary emboli. J Cardiovasc Surg 1999; 40:457-461.
3. Akomea AC, Dussek JE, Anderson DR. Pulmonary artery sarcoma mimicking pulmonary embolism: successful surgical intervention. Ann Thorac Surg 1996; 61:1536-1538.
4. Nonomura A, Kurumaya H, Kono N, et al. Primary pulmonary artery sarcoma. Report of two autopsy cases studied by immunohistochemistry and electron microscopy, and review of 110 cases reported in the literature. Acta Pathol Jpn 1988; 38:883-896.
5. Schriner RW, Ryu JH, Edwards WD. Microscopic pulmonary tumor embolism causing subacute cor pulmonale: a difficult antemortem diagnosis. Mayo Clin Proc 1991; 66:143-148.
6. Burke AP, Virmani R. Sarcomas of the great vessels. A clinicopathologic study. Cancer 1993; 71:1761-1773.
7. Bleisch VR, Kraus FT. Polypoid sarcoma of the pulmonary trunk: analysis of the literature and report of a case with leptomeric organelles and ultrastructural features of rhabdomyosarcoma. Cancer 1980; 46:314-324.
8. McGlennen RC, Manivel JC, Stanley SJ, et al. Pulmonary artery trunk sarcoma: a clinicopathologic, ultrastructural, and immunohistochemical study of four cases. Mod Pathol 1989; 2:486-494.
9. Baker PB, Goodwin RA. Pulmonary artery sarcomas. A review and report of a case. Arch Pathol Lab Med 1985; 109:35-39.
10. Cox JE, Chiles C, Aquino SL, et al. Pulmonary artery sarcomas: a review of clinical and radiologic features. J Comput Assist Tomogr 1997; 21:750-755.
11. Mortele KJ, McTavish J, Ros PR.Current techniques of computed tomography. Helical CT, multidetector CT, and 3D reconstruction. Clin Liver Dis 2002; 6:29-52.
12. Choi EY, Yoon YW, Kwon HM, et al. A case of pulmonary artery intimal sarcoma diagnosed with multislice CT scan with 3D reconstruction. Yonsei Med J 2004; 45:547-551.
13. Weinreb JC, Davis SD, Berkmen YM, et al. Pulmonary artery sarcoma: evaluation using Gd-DTPA. J Comput Assist Tomogr 1990; 14:647-649.
14. Kauczor HU, Schwickert HC, Mayer E, et al. Pulmonary artery sarcoma mimicking chronic thromboembolic disease: computed tomography and magnetic resonance imaging findings. Cardiovasc Intervent Radiol 1994; 17:185-189.
15. Anderson MB, Kriett JM, Kapelanski DP, et al. Primary pulmonary artery sarcoma: a report of six cases. Ann Thorac Surg 1995; 59:1487-1490.
16. Head HD, Flam MS, John MJ, et al. Long-term palliation of pulmonary artery sarcoma by radical excision and adjuvant therapy. Ann Thorac Surg 1992; 53:332-334.
17. Mattoo A, Fedullo PF, Kapelanski D, et al. Pulmonary artery sarcoma: a case report of surgical cure and 5-year follow-up. Chest 2002; 122:745-747.
18. Van Oosterom AT, Mourisden HT, Nielsen OS, et al. Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients. Eur J Cancer 2002; 38:2397-2406.
19. Patel SR, Vadhan-Raj S, Burgess MA, et al. Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol 1998; 21:317-321.
20. D'Incalci M, Jimeno J. Preclinical and clinical results with the natural marine product ET-743. Expert Opin Investig Drugs 2003; 12:1843-1853.
21. Yovine A, Riofrio M, Blay JY, et al. Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients. J Clin Oncol 2004; 22:890-899.
22. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279:577-580.
23. Gusterson B, Cowley G, McIlhinney J, et al. Evidence for increased epidermal growth factor receptors in human sarcomas. Int J Cancer 1985; 36:689-693.
24. Hayes AJ, Mostyn-Jones A, Koban MU, et al. Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma. Br J Surg 2004; 91:242-247.
25. Mouridsen HT, Bastholt L, Somers R, et al. Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer Clin Oncol 1987; 23:1477-1483.
26. Patel SR, Vadhan-Raj S, Papadopolous N, et al. High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies - dose-response and schedule dependence. J Clin Oncol 1997; 15:2378-2384.
27. Van Hoesel QG, Verweij J, Catimel G, et al. Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group. Ann Oncol 1994; 5:539-542.
28. Balcerzak SP, Benedetti J, Weiss GR, et al. A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A Southwest Oncology Group study. Cancer 1995; 76:2248-2252.
29. Samson MK, Baker LH, Benjamin RS, et al. Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group study. Cancer Treat Rep 1979; 63:2027-2029.
30. Fidias P, Demetri GD, Harmon DC. Navelbine shows activity in previously treated sarcoma patients: phase II results from MGH/Dana-Farber/Partners Cancer Care study. Proc Am Soc Clin Oncol 1998; 17:513a (Abstract #1977).
31. Patel SR, Jenkins J, Papadopoulos NE, et al. Preliminary results of a two-arm phase 2 trial of gemcitabine in patients with gastrointestinal leiomyosarcomas and other soft-tissue sarcomas (STS). Sarcoma 1999; 3:56.
32. Omura GA, Major FJ, Blessing JA, et al. A randomized study of Adriamycin with and without dimethyl triazeno imidazole carboxamide in advanced uterine sarcomas. Cancer 1983; 52:626-632.
33. Muss HB, Bundy B, DiSaia PJ, et al. Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group). Cancer 1985; 55:1648-1653.
34. Cruz AB Jr, Thames EA Jr, Aust JB, et al. Combination chemotherapy for soft-tissue sarcomas: a phase III study. J Surg Oncol 1979; 11:313-323.
35. Schoenfeld DA, Rosenbaum C, Horton J, et al. A comparison of Adriamycin versus vincristine and Adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma. Cancer 1982; 50:2757-2762.
36. Santoro A, Tursz T, Mouridsen H, et al. Doxorubicin versus CyVADIC versus doxorubicin plus ifosramide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1995; 13:1537-1545.
37. Antman K, Crowley J, Balcerzak SP, et al. An Intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosramide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 1993; 11:1276-1285.
38. Nielsen OS, Dombernowsky P, Mouridsen H, et al. High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group. Br J Cancer 1998; 78:1634-1639.
39. Van Glabbeke M, van Oosterom AT, Oosterhuis JW, et al. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcomas: an analysis of 2,185 patients treated with anthracycline containing first-line regimens - an European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Study Group. J Clin Oncol 1999; 17:150-157.
40. Garcia-Carbonera R, Supko JG, Manola J, et al. Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy. J Clin Oncol 2004; 22:1480.
41. Kuenen BC, Tabernero J, Baselga J, et al. Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcoma. Clin Cancer Res 2003; 9:1648-1655.
42. Maki RG, Kraft A, Skoog L, et al. A phase II study of bortezomib (PS-341, Velcade) in sarcomas. Proc Connective Tissue Oncol Soc 2003; 9:148.
43. Schuff-Werner P, Bartsch H, Schremi W, et al. Treatment of soft tissue sarcoma with recombinant alpha-interferon. Antiviral Res 1984; 3:93.
44. Harris J, Das Gupta T, Vogelzang N, et al. Treatment of soft tissue sarcoma with ibroblast interferon (beta-interferon): an American Cancer Society/Illinois Cancer Council study. Cancer Treat Rep 1986; 70:293-294.